Results 41 to 50 of about 158,397 (231)

Abstracts of the communications presented during the 14th Hungarian Conference on Rabbit Production, Kaposvár (Hungary). May 22, 2002

open access: yes, 2002
World Rabbit Science (2002). Abstracts of the communications presented during the 14th Hungarian Conference on Rabbit Production, Kaposvár (Hungary). May 22, 2002. World Rabbit Science. 10(4):171-180.
World Rabbit Science
core   +1 more source

Abstracts of the International Conference on Rabbit Production [PDF]

open access: yes, 2008
not available.World Rabbit Science (2008). Abstracts of the International Conference on Rabbit Production. World Rabbit Science. 16(1).
World Rabbit Science   +1 more
core   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

Abstracts of the communications presented during the 6th World Rabbit Congress: REPRODUCTION & REPRODUCTION PHYSIOLOGY. Toulouse, July 9-12, 1996

open access: yes, 1996
World Rabbit Science (1996). Abstracts of the communications presented during the 6th World Rabbit Congress: REPRODUCTION & REPRODUCTION PHYSIOLOGY. Toulouse, July 9-12, 1996. World Rabbit Science. 04:58-67.
World Rabbit Science
core   +1 more source

Abstracts of the 19th Hungary conference on rabbit production. KAPOSVÁR [PDF]

open access: yes, 2007
World Rabbit Science (2007). Abstracts of the 19th Hungary conference on rabbit production. KAPOSVÁR. World Rabbit Science. 15(4).
World Rabbit Science   +1 more
core   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Abstracts of the communications presented during the 9th French Rabbit Days. Paris, November 28-29th 2001: REPRODUCTION

open access: yes, 2001
World Rabbit Science (2001). Abstracts of the communications presented during the 9th French Rabbit Days. Paris, November 28-29th 2001: REPRODUCTION. World Rabbit Science. 9.
World Rabbit Science
core   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy